Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
0.762
-0.025 (-3.21%)
At close: Apr 28, 2026, 4:00 PM EDT
0.783
+0.021 (2.80%)
After-hours: Apr 28, 2026, 6:40 PM EDT
Tenon Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Tenon Medical.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Tenon Medical.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +293.86% | Apr 9, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $22 → $8 | Strong Buy | Maintains | $22 → $8 | +950.28% | Nov 15, 2024 |
| Benchmark | Benchmark | Buy Reiterates $24 | Buy | Reiterates | $24 | +3,050.85% | Aug 14, 2024 |
| Benchmark | Benchmark | Buy Maintains $40 → $24 | Buy | Maintains | $40 → $24 | +3,050.85% | Apr 15, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +62,916.94% | Mar 10, 2023 |
Financial Forecast
Revenue This Year
6.55M
from 3.94M
Increased by 65.95%
Revenue Next Year
9.85M
from 6.55M
Increased by 50.54%
EPS This Year
-0.90
from -1.70
EPS Next Year
-0.64
from -0.90
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.6M | 12.6M | |||
| Avg | 6.5M | 9.9M | |||
| Low | 5.5M | 7.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 91.5% | 92.3% | |||
| Avg | 65.9% | 50.5% | |||
| Low | 40.1% | 9.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.79 | -0.53 | |||
| Avg | -0.90 | -0.64 | |||
| Low | -0.99 | -0.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.